Annals of Oncology

Aims & Scope

Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.

Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies.

Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	65.4
2024	56.70

SJR (SCImago Journal Rank)

Year	Value
2024	19.072

Quartile

Year	Value
2024	Q1

Journal Rank

Year	Value
2024	16

Journal Citation Indicator

Year	Value
2024	11555

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

  Citation: 2936

  Authors: A., W.C., A.S., R.D., B., H.-J.

• Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

  Citation: 2873

  Authors: A., E.P., A.S., R.D., M., B., H.-J., Kathy S., Fabrice, Jonas, Hervé, Denisse, Harold, Fatima, Monica, Alan S., Marco, Alberto, Giuseppe, Nancy E., Angelo, Bent, John F., Richard D., Michael, Aron, Pamela, Paul E., Jay R., Daniel F., Clifford A., James N., Jacek, Zefei, Per, Sibylle, Monica, Moise, C., Ann H., Frédérique, Charles M., Martine J., Kathleen I., Emiel J.T., Felix, Vladimir, Zhi-Ming, Ian, Beat, Masakazu, Andrew, Michael, Giuseppe, Toru, Nicholas, Eric P., William C.

• ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

  Citation: 2698

  Authors: E., A., R., A., J.H., D., E., A., A., G., F., A., E., J.-Y., M., A., A., T., K., V., P., C.-H., R., P., B., T., K., N., P., W.J.G., D., G., P., T.J., C., J., A., R., W., H.J., J., J., S., H., T., A., D.

• The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

  Citation: 2396

  Authors: R., C., S., N., F., G., S., G., F.L., F., E.A., E.A., W.F., A.L., J., C., H., M., G., J., Z., T., D.L., K.H., J.S., S., C., G., S., S., K., S.

• Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

  Citation: 2067

  Authors: T.A., M., E., C., S.A., A., S.

• Estimates of the cancer incidence and mortality in Europe in 2006

  Citation: 1820

  Authors: J., P., M., M., M., P.

• Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Citation: 1726

  Authors: J.B.A.G., F., C., K.M., S., J., K.

• Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Citation: 1719

  Authors: D., S., K., S., E.F., C., T.S., M., P.E., M.D., S.

• Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Citation: 1629

  Authors: F., S., S., F., P., I.T., S., E.

• Prevalence of pain in patients with cancer: a systematic review of the past 40 years

  Citation: 1461

  Authors: M.H.J., J.M., A.G., H.C., M., J.

---